Virginia Villaverde-García1, Tatiana Cobo-Ibáñez2, Gloria Candelas-Rodríguez3, Daniel Seoane-Mato4, Petra Díaz Del Campo-Fontecha4, Mercedes Guerra4, Santiago Muñoz-Fernández2, Juan D Cañete5. 1. Rheumatology Department, Hospital Universitario de Móstoles, Universidad Francisco de Vitoria, Río Júcar s/n, 28935 Móstoles, Madrid, Spain. Electronic address: virginia.villaverde@yahoo.es. 2. Rheumatology Department, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Madrid, Spain. 3. Rheumatology Department, Hospital Universitario Clínico San Carlos, Universidad Complutense de Madrid, Madrid, Spain. 4. Research Unit, Spanish Society of Rheumatology, Madrid, Spain. 5. Arthritis Unit. Rheumatology Department, Hospital Clinic de Barcelona and IDIBAPS, Barcelona, Spain.
Abstract
OBJECTIVES: To evaluate the association between smoking and clinical parameters and structural damage in axial spondyloarthritis (axSpA). METHODS: We systematically searched MEDLINE, EMBASE and Cochrane Library till November 2015. We selected articles that analysed the smoking impact on disease activity, functional status, structural damage, physical mobility and life quality. Independent extraction of articles by 2 authors using predefined data fields was performed. Studies quality was graded according to the Oxford Level of Evidence scale. RESULTS: A total of 17 articles were selected for inclusion: 2 case-control, 11 cross-sectional and 4 prospective cohort studies, which analysed 4694 patients. Weak evidence suggested a smoking effect on pain, overall assessment of health, disease activity, physical mobility and life quality in ankylosing spondylitis (AS). Moderate-good evidence revealed higher HAQ-AS among smokers (0.025units/y; 95% CI: 0.0071-0.0429; p = 0.007). Every additional unit of ASDAS resulted in an increase of 1.9 vs. 0.4 mSASSS units/2y in AS smokers vs. non-smokers. Good evidence revealed that cigarette smoking and smoking intensity was associated with spinal radiographic progression in axSpA [mSASSS ≥2 units/2y: OR = 2.75, 95% CI: 1.25-6.05, p=0.012; mSASSS progression in heavy smokers (>10 cigarettes/d): OR = 3.57, 95% IC: 1.33-9.60, p = 0.012]. CONCLUSIONS: Published data indicate that smoking has a dose-dependent impact on structural damage progression in axSpA. There is worse HAQ among AS smokers compared to non-smokers. Respect to pain, overall assessment of health, disease activity, physical mobility and life quality, although the evidence level is poor, all evidence points in the same direction: smoking AS patients are worse than non-smoking.
OBJECTIVES: To evaluate the association between smoking and clinical parameters and structural damage in axial spondyloarthritis (axSpA). METHODS: We systematically searched MEDLINE, EMBASE and Cochrane Library till November 2015. We selected articles that analysed the smoking impact on disease activity, functional status, structural damage, physical mobility and life quality. Independent extraction of articles by 2 authors using predefined data fields was performed. Studies quality was graded according to the Oxford Level of Evidence scale. RESULTS: A total of 17 articles were selected for inclusion: 2 case-control, 11 cross-sectional and 4 prospective cohort studies, which analysed 4694 patients. Weak evidence suggested a smoking effect on pain, overall assessment of health, disease activity, physical mobility and life quality in ankylosing spondylitis (AS). Moderate-good evidence revealed higher HAQ-AS among smokers (0.025units/y; 95% CI: 0.0071-0.0429; p = 0.007). Every additional unit of ASDAS resulted in an increase of 1.9 vs. 0.4 mSASSS units/2y in AS smokers vs. non-smokers. Good evidence revealed that cigarette smoking and smoking intensity was associated with spinal radiographic progression in axSpA [mSASSS ≥2 units/2y: OR = 2.75, 95% CI: 1.25-6.05, p=0.012; mSASSS progression in heavy smokers (>10 cigarettes/d): OR = 3.57, 95% IC: 1.33-9.60, p = 0.012]. CONCLUSIONS: Published data indicate that smoking has a dose-dependent impact on structural damage progression in axSpA. There is worse HAQ among AS smokers compared to non-smokers. Respect to pain, overall assessment of health, disease activity, physical mobility and life quality, although the evidence level is poor, all evidence points in the same direction: smoking AS patients are worse than non-smoking.
Authors: Ho Yin Chung; Lai Shan Tam; Shirley Chiu Wai Chan; Jason Pui Yin Cheung; Pui Yan Wong; Chu Oi Ciang; Hoi Yan Ng; Mei Yan Law; Tin Lok Lai; Ching Han Wong Journal: Ther Adv Musculoskelet Dis Date: 2020-10-13 Impact factor: 5.346
Authors: Joshua B Lewis; Kelsey M Hirschi; Juan A Arroyo; Benjamin T Bikman; David L Kooyman; Paul R Reynolds Journal: Int J Mol Sci Date: 2017-03-17 Impact factor: 5.923
Authors: Cristina Fernández-Carballido; María A Martín-Martínez; Carmen García-Gómez; Santos Castañeda; Carlos González-Juanatey; Fernando Sánchez-Alonso; Rosario García de Vicuña; Celia Erausquin-Arruabarrena; Javier López-Longo; María D Sánchez; Alfonso Corrales; Estefanía Quesada-Masachs; Eugenio Chamizo; Carmen Barbadillo; Javier Bachiller-Corral; Tatiana Cobo-Ibañez; Ana Turrión; Emilio Giner; Javier Llorca; Miguel A González-Gay Journal: Arthritis Care Res (Hoboken) Date: 2020-05-14 Impact factor: 4.794
Authors: Jin Xian Huang; Ho Yin Chung; Eva Tze Fung Chui; Kam Ho Lee; Shirley Chiu Wai Chan; Helen Hoi Lun Tsang; Alexandra Hoi Yan Ng Journal: Rheumatol Adv Pract Date: 2019-12-18
Authors: M J García; M Pascual; C Del Pozo; A Díaz-González; B Castro; L Rasines; J Crespo; M Rivero Journal: Sci Rep Date: 2020-07-01 Impact factor: 4.379
Authors: Maud Wieczorek; James Martin Gwinnutt; Maxime Ransay-Colle; Suzanne Mm Verstappen; Francis Guillemin; Andra Balanescu; Heike Bischoff-Ferrari; Annelies Boonen; Giulio Cavalli; Savia de Souza; Annette de Thurah; Thomas Ernst Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja A Stamm; Karen Walker-Bone; Joep Welling; Mirjana Zlatkovic-Svenda Journal: RMD Open Date: 2022-03